Skip to main content
. 2021 Feb 7;13(2):234. doi: 10.3390/pharmaceutics13020234

Figure 9.

Figure 9

In vitro drug release profile of dexamethasone-based formulations with TPGS or Idebenone respectively. DX 0.2% (A), DX 0.2% + Idebenone 1 µM (B), DX 0.2% + TPGS 0.02% (C). Data are represented as mean ± standard deviation (SD) from 3 different batches (n = 3).